Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Multiple sclerosis causing a partial sixth nerve palsy.
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
MYRAC Rx
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Management of children with multiple sclerosis.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Plasma exchange in severe attacks of neuromyelitis optica.
Pages
« first
‹ previous
…
165
166
167
168
169
170
171
172
173
…
next ›
last »